Our skilled scientists develop tailored methods to streamline the clinical development phase, enabling diverse PD/PK testing and clinical studies across multiple biological matrices, biomarkers, and metabolites. With expertise in plasma, serum, blood, CSF, urine, and more, we provide comprehensive support in method development, validation, analysis, and interpretation, adhering to regulatory guidelines. Performing in vitro non-clinical studies alongside clinical trials, our dedicated facility and proven track record ensure accurate and transparent results for up to 360,000 samples annually. Equipped with the latest Bruker timsTOF, Sciex LC/MS/MS, MSD ECL S 600, and more, we develop highly sensitive and selective GLP assays.
Specializing in PK testing, Sannova will deliver comprehensive insights into drug behavior and metabolism. Our expert scientists leverage sophisticated analytical platforms to precisely quantify drug concentrations and map detailed concentration-time profiles throughout the body. This deep characterization of drug pharmacokinetics helps optimize dosing strategies and supports key development decisions, ultimately accelerating the path to successful therapeutics.
Download the Guide and Discover The 3 Pillars of Bioanalytical Success
Addressing Bioanalytical Method Development Challenges from Preclinical to Clinical Trials
Choose Sannova for your PK testing to experience exceptional quality, personalized services and excellent results, all delivered as quickly as our commitment to excellence allows.